Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours. joms [Internet]. 2022 Jan. 30 [cited 2026 Jan. 30];17(1):1-7. Available from: http://sebhau.edu.ly/journal/joms/article/view/1892